About Orbuculum
Orbuculum is a company based in Graz (Austria) founded in 2017 by Faiz Ahmad and Pranav Gangwal. Orbuculum has raised $34.74 thousand across 2 funding rounds from investors including Axilor Ventures, Pratithi Investments and Srinath Batni. Orbuculum operates in a competitive market with competitors including Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and Champion Oncology, among others.
- Headquarter Graz, Austria
- Founders Faiz Ahmad, Pranav Gangwal
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orbuculum Genolytics Private Limited
- Date of Incorporation 25 Aug, 2017
- Jurisdiction Indore, Madhya Pradesh, India
-
Annual Revenue
$3.58 K (USD)0as on Mar 31, 2020
-
Net Profit
-$9.13 K (USD)0as on Mar 31, 2020
-
EBITDA
-$9.28 K (USD)0as on Mar 31, 2020
-
Total Equity Funding
$34.74 K (USD)
in 2 rounds
-
Latest Funding Round
$19.87 K (USD), Seed
Mar 20, 2020
-
Investors
Axilor Ventures
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Orbuculum
Orbuculum has successfully raised a total of $34.74K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $19.87 thousand completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Orbuculum
Orbuculum has secured backing from 4 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Axilor Ventures, Pratithi Investments and Srinath Batni.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in early-stage startups in technology sectors.
|
Locked | Locked | Locked | |
|
Private investment arm of Kris Gopalakrishnan Family Office.
|
Locked | Locked | Locked | |
|
Healthcare and multiple sectors are targeted by the single-family office.
|
Locked | Locked | Locked |
Investor details for Orbuculum
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orbuculum
Investment portfolio details for Orbuculum
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orbuculum
Detailed financials for Orbuculum
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orbuculum Comparisons
Peer comparison for Orbuculum
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orbuculum
Orbuculum operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and Champion Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Drug response assays are performed using murine in vivo models.
|
|
| Locked | Locked | Locked |
Humanized models and drug screening technologies are developed for research.
|
Detailed competitors of Orbuculum
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orbuculum
Complete news archive for Orbuculum
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orbuculum
Orbuculum was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Orbuculum is headquartered in Graz, Austria. It is registered at Graz, Styria, Austria.
Orbuculum is a funded company, having raised a total of $34.74K across 2 funding rounds to date.
Annual revenue of Orbuculum is $3.58K as on Mar 31, 2020.
Orbuculum was founded in 2017 and is based in Graz, Austria. Operations focus on the health technology sector, where genomic data is utilized to develop predictive solutions for diseases including cancer, cardiac conditions, neurological disorders, cardiovascular issues, and Mendelian diseases. These tools are employed by medical professionals for disease screening and prediction purposes.
Orbuculum's top competitors include Biocytogen, Applied StemCell and GenOway.
Orbuculum has 4 investors. Key investors include Axilor Ventures, Pratithi Investments, Srinath Batni, and Prathithi Investment.
The valuation of Orbuculum is $532.29K as of Mar 2020.